If ADHD is making it hard to start tasks, keep track of details, manage time, or follow through, you have options. ADHD treatment may include stimulant medication, non-stimulant medication, ADHD therapy, or a combination tailored to your needs.
At Light-tunnel Behavioral Health Services Inc. in New Haven, Connecticut, psychiatric care is personalized to your symptoms, health history, daily responsibilities, and preferences. Dr. Omolola Aragbada, PMHNP-BC, is one of the psychiatric providers at the practice. A thoughtful comparison can help you prepare for a conversation about what may fit you, not replace an individual evaluation.
How ADHD can affect daily life
ADHD is a neurodevelopmental condition that can affect attention, impulse control, planning, working memory, and task initiation. These skills are often grouped under executive function.
You might think of executive function as a brain’s air-traffic-control system. Your ideas and responsibilities are the planes; ADHD can make it harder to decide which one should land first, remember the instructions, or switch tracks when something changes. That struggle is not a character flaw. It is a reason to seek support that fits your life.
A thorough evaluation helps determine whether ADHD best explains your experiences. It may also consider sleep, anxiety, depression, mood symptoms, substance use, medical factors, and other conditions that can affect concentration.
ADHD treatment options at a glance
| Option | Potential advantages | Considerations |
|---|---|---|
| Stimulants: methylphenidate or amphetamine-based medications | Often act relatively quickly and have substantial evidence for reducing core ADHD symptoms | May affect appetite, sleep, heart rate, or blood pressure; require individualized prescribing and monitoring |
| Non-stimulants: atomoxetine, viloxazine, or guanfacine | May suit people who cannot take, do not tolerate, or prefer not to use stimulants | Effects and evidence vary by medication; some take longer to assess, and side effects still require monitoring |
| ADHD therapy: often CBT-informed and skills-focused | Builds practical strategies for planning, organization, routines, and self-criticism | Requires practice over time; may not be enough by itself for everyone |
| Medication plus therapy | Can address symptoms while building tools for daily life | Involves more than one part of care and may take time to find the right balance |
No option is automatically best for everyone. Your age, health history, symptom pattern, treatment goals, and preferences all matter.
Stimulants: methylphenidate vs. amphetamine-based medication
Stimulants include medications based on methylphenidate and amphetamines. They affect dopamine and norepinephrine signaling in brain networks involved in attention and behavioral regulation. One everyday metaphor: they may help useful signals come through more clearly in a noisy room.
Both classes have evidence of benefit, but individual response differs. A randomized controlled trial (RCT) found that methylphenidate improved ADHD symptoms in adults compared with placebo (Philipsen et al., 2015). A separate placebo-controlled trial found symptom improvement with lisdexamfetamine in adults with ADHD (Wigal et al., 2010). These separate trials do not establish that one medication works better for every person.
A psychiatric provider can discuss which medication, if any, is appropriate for you. Monitoring may include symptom changes, appetite, sleep, mood, heart rate, and blood pressure. Stimulants are controlled medications; safe use means taking them only as prescribed and not sharing them.
Non-stimulants: atomoxetine vs. viloxazine vs. guanfacine
Non-stimulants are another medication-management option. They are not simply “weaker stimulants”; they work differently, and the best fit depends on your clinical situation.
- Atomoxetine is a non-stimulant option with evidence from adult RCTs. In a placebo-controlled trial, atomoxetine improved ADHD symptoms in adults (Michelson et al., 2003). Its benefits may take time to assess, so your provider can help set expectations and follow-up.
- Viloxazine extended-release is approved in the United States for ADHD in adults and children. In a six-week adult RCT, viloxazine improved ADHD symptom scores more than placebo; the trial also reported side effects, including insomnia, fatigue, nausea, and reduced appetite (Nasser et al., 2022).
- Guanfacine extended-release may be considered in selected situations. An adult placebo-controlled trial found symptom improvement, while also highlighting the need to weigh tolerability and monitor effects such as sleepiness and blood pressure (Iwanami et al., 2020). Adult use and prescribing considerations depend on individual circumstances.
These studies are not direct head-to-head comparisons of all three medications. Your provider can explain the evidence and limitations in the context of your history, other medications, and goals.
ADHD therapy: building skills that work in real life
ADHD therapy can help turn insight into practical supports. Cognitive behavioral therapy (CBT) approaches may focus on breaking tasks into smaller steps, planning realistically, managing procrastination, and responding to self-criticism with more useful strategies.
Therapy may help you build systems such as:
- One calendar for appointments and deadlines
- Reminders that say what action to take, not just when
- A short, repeatable routine for starting difficult tasks
- A planned place for keys, medication, or work materials
- Regular check-ins to notice what is helping and adjust what is not
Therapy is not about expecting you to “try harder.” It is about designing supports around how you function and practicing skills that can make daily demands more manageable.
Medication, therapy, or combined treatment?
Medication may reduce the intensity of core symptoms; therapy may help you build routines and coping tools. Some people prefer to begin with one approach, while others find that a combination makes sense.
An RCT of adults receiving methylphenidate and psychological treatment found that structured group psychotherapy did not outperform individual clinical management on the trial’s primary ADHD symptom measure, though some broader outcomes favored psychotherapy (Philipsen et al., 2015). A later meta-analysis of RCTs found that CBT combined with medication can improve adult ADHD symptoms more than medication alone in some follow-up periods, although results varied over time (Young et al., 2024). This supports considering combined care when useful, not assuming it is necessary for everyone.
| Your situation or preference | A topic to discuss with your provider |
|---|---|
| You want to understand medication options | Potential benefits, side effects, monitoring, and how response will be evaluated |
| You prefer to avoid medication or cannot take a particular medicine | ADHD-focused therapy and practical environmental supports |
| Medication helps, but important difficulties remain | Adding therapy or skills-based support |
| Side effects or limited benefit are a concern | Whether a medication adjustment or another treatment approach is appropriate |
Medication management and self-pay care in New Haven
Medication management involves more than a prescription. It can include reviewing your health and medication history, discussing goals, monitoring benefits and side effects, and revisiting the plan as your needs change.
At Light-tunnel Behavioral Health Services Inc. in New Haven, psychiatric care and therapy are tailored to the individual. Self-pay clients can ask about evaluation, medication management, and therapy services, along with fees and payment options before beginning care. You do not need to assume one treatment approach is right for you before speaking with a provider. The practice also accepts a range of insurance plans; coverage varies, so check your benefits and any authorization requirements.
Learn more about medication management, psychotherapy services, accepted insurance, or contact the practice.
What to do, and what to avoid
Do:
- Share your health history, current medications, supplements, and treatment goals with your provider.
- Ask how benefit and side effects will be monitored.
- Contact your provider about concerning changes in sleep, appetite, mood, or functioning.
- Use practical reminders and routines while you explore treatment.
Avoid:
- Starting, stopping, or changing medication without guidance from your prescriber.
- Taking someone else’s medication or sharing yours.
- Assuming that another person’s experience predicts your own response.
- Treating online comparisons as a substitute for a personalized evaluation.
Medical safety disclaimer and emergency resources
This article is for general education. It does not diagnose ADHD or provide individual medical advice. Medication decisions require assessment by a qualified healthcare professional. If you experience a serious or potentially life-threatening medical reaction, call 911 or go to an emergency department.
If you are having thoughts of suicide, feel unable to stay safe, or are concerned about someone’s immediate safety, call or text 988 in the United States for the Suicide & Crisis Lifeline. Call 911 if there is immediate danger.
References
- Iwanami, A., et al. (2020). Efficacy and safety of guanfacine extended-release in adults with ADHD: Results from a randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 81(3), 19m12979. https://doi.org/10.4088/JCP.19m12979
- Michelson, D., et al. (2003). Once-daily atomoxetine treatment for adults with ADHD: A 6-month, double-blind trial. Biological Psychiatry, 53(2), 112–120. https://doi.org/10.1016/S0006-3223(02)01634-3
- Nasser, A., et al. (2022). A phase III, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of viloxazine extended-release capsules in adults with ADHD. CNS Drugs, 36, 897–914. https://doi.org/10.1007/s40263-022-00938-w
- Philipsen, A., et al. (2015). Effects of group psychotherapy, individual counseling, methylphenidate, and placebo in the treatment of adult ADHD: A randomized clinical trial. JAMA Psychiatry, 72(12), 1199–1210. https://doi.org/10.1001/jamapsychiatry.2015.2146
- Wigal, T., et al. (2010). Randomized, double-blind, placebo-controlled crossover study of lisdexamfetamine in adults with ADHD using a simulated workplace environment. Behavioral and Brain Functions, 6, 34. https://doi.org/10.1186/1744-9081-6-34
- Young, S., et al. (2024). Efficacy of cognitive behavioral therapy combined with pharmacotherapy versus pharmacotherapy alone in adult ADHD: A systematic review and meta-analysis. Journal of Attention Disorders. https://doi.org/10.1177/10870547231214969
Continue the Series
For another side-by-side look at mental health care options, read Anxiety Treatment in New Haven: Therapy, Medication, or Interventional Care? A Side-by-Side Comparison.